Company: DHR
Filing Date: 2025-10-21
Form Type: 10-Q
Source: 0000313616-25-000182
Chunk: 82

Company: DANAHER CORP /DE/
Filing Date: 2025-10-21
Form: 10-Q
Item: Item 8
Chunk 82
---
.0 6.4 3.4 6.3 Weighted average common shares outstanding used in Diluted EPS713.7 729.4 717.9 740.1 Basic EPS $1.28 $1.13 $3.38 $3.83 Diluted EPS $1.27 $1.12 $3.37 $3.80 

8

NOTE 4.  REVENUE

The following tables present the Company’s revenues disaggregated by geographical region and revenue type for the three and nine-month periods ended September 26, 2025 and September 27, 2024 ($ in millions).  Sales taxes and other usage-based taxes collected from customers are excluded from revenue.BiotechnologyLife SciencesDiagnosticsTotalFor the Three-Month Period Ended September 26, 2025:Geographical region:North America(a)$624 $728 $1,228 $2,580 Western Europe587 392 417 1,396 Other developed markets(b)89 130 97 316 High-growth markets(c)498 542 721 1,761 Total$1,798 $1,792 $2,463 $6,053 Revenue type:Recurring$1,590 $1,216 $2,211 $5,017 Nonrecurring208 576 252 1,036 Total$1,798 $1,792 $2,463 $6,053 For the Three-Month Period Ended September 27, 2024:Geographical region:North America(a)$503 $796 $1,157 $2,456 Western Europe587 365 368 1,320 Other developed markets(b)78 120 101 299 High-growth markets(c)485 501 737 1,723 Total$1,653 $1,782 $2,363 $5,798 Revenue type:Recurring$1,422 $1,228 $2,127 $4,777 Nonrecurring231 554 236 1,021 Total$1,653 $1,782 $2,363 $5,798 

9

BiotechnologyLife SciencesDiagnosticsTotalFor the Nine-Month Period Ended September 26, 2025:Geographical region